These observations suggest that the putative kinase activity of STYK1 and its dimerization are not required to enhance the anchorage-independent growth in EGFR-mutant NSCLC cells treated with EGFR TKI. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.